By Jenny Ruth
Wednesday 22nd April 2009 |
Text too small? |
Nuplex Industries' up to $156 million capital raising "should alleviate the financial risk of the company and allow management to pursue operational improvements in a difficult global economic environment," says McDouall Stuart.
While deteriorating global economic conditions have reduced demand for Nuplex's products following de-stocking by customers, there is some evidence that trend is reversing, it says. That provides the company "with confidence to provide EBITDA (earnings before interest, tax, depreciation and amortisation) of around $86 million for the current year," it says.
Nuplex has demonstrated international competitiveness through its technology and operational expertise in the resins business, which accounted for 81% of operating earnings last year. Its 2004 purchase of Akzo Nobel's coating resin business propelled Nuplex into a global player, it says.
McDouall Stuart is forecasting net profit for the year ending June will fall to $19 million from $53.4 million last year but will rise to $34 million in 2010 and to $40.6 million in 2011.
It is predicting the share price will rise after the capital raising if management delivers on its earnings guidance. The 23 cents a share seven-for-one rights issue compares with last week's 37 cents NZX price and McDouall Stuart values the shares at 67 cents.
Recommendation: Buy
McDouall Stuart rates NPX as BUY.
No comments yet
Nuplex targets half billion dollar Asian sales within five years
Nuplex FY profit drops 31 percent on weak ANZ, EMEA markets, writedowns
Nuplex cuts FY guidance again as Australian manufacturing splutters; stock drops
Nuplex 1H profit misses forecasts; annual guidance cut on strong kiwi, weak trading conditions
Nuplex looks at imputing future dividends, flags increased earnings
Nuplex plans restructuring in Australia, NZ to cut 2013 profit
Nuplex FY profit falls, guidance met
Nuplex raises US$105M in US private placement
Nuplex sees full-year earnings at bottom of range
Nuplex 1H profit drops 23% on Australasian weakness